Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma
ConclusionFollow-up cachexia had an early onset, but was not a prognostic factor for overall survival in patients with PDAC. Some adverse events tended to be more frequent in patients with follow-up cachexia than in those without follow-up cachexia.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Pancreas | Pancreatic Cancer | Study | Toxicology | Weight Loss